Skip to main content
Corporate Site
Kenvue-WLDS

Aveeno Baby® Eczema Therapy

Gentle care for babies, effective relief of kids’ eczema symptoms

The Aveeno Baby® difference

More than 1% colloidal oatmeal, a unique Triple Oat® Complex for eczema-prone skin

Formulation Matters: The unique formula in Aveeno® provides greater efficacy & stability. This unique blend of components provides multiple benefits for sensitive skin.

  • 9 out of 10 patients prefer Aveeno® Colloidal Oatmeal Lotion over its vehicle

  • Significant improvement in scaling, overall dryness and hydration.

View study

Colloidal oatmeal

  • The only FDA-approved OTC skin protectant ingredient for eczema care

  • Supports the skin microbiome1

Oat oil

  • Helps reinforces the developing moisture barrier2,3

  • Promotes skin's endogenous production of ceramides up to 3X vs untreated2,3

Oat extract

  • Naturally rich in oat polyphenols (avenanthramides)3,4

  • Works with oat flour + oat oil to maintain skin comfort3,4

  • Provides soothing benefits3,4

View study

Clinically proven routine relieves eczema symptoms in 1 day

Products in study: Aveeno® Baby cleansing therapy moisturizing wash & Aveeno® Baby eczema therapy moisturizing cream  

% improvement in EASI scores from baseline
(Global Eczema Area Severity Index)

  • 93.0% agree that the routine left baby’s skin appearing less red or irritated

  • 86.1% reported that the routine improved their child’s itching & scratching

Clinical trial to evaluate the efficacy of Aveeno® Baby eczema therapy nighttime balm in the management of mild to moderate atopic dermatitis in infants and toddlers

Products in study: Aveeno Baby® Eczema Therapy Nighttime Balm

51% improvement in EASI scores at day 7

Dermatologists assessment: EASI composite score (Global Eczema Area Severity Index)

Immediate and long-lasting moisturization

Skin hydration (corneometer)

References

  1. Liu-Walsh F, Tierney NK, Hauschild J, et al. Prebiotic colloidal oat supports the growth of cutaneous commensal bacteria including s. epidermidis and enhances the production of lactic acid. Clin Cosmet Investig Dermatol. 2021;14:73-82

  2. Chon SH, Tannahill R, Yao X, Southall MD, Pappas A. Keratinocyte differentiation and upregulation of ceramide synthesis induced by an oat lipid extract via the activation of PPAR pathways. Exp Dermatol. 2015;24(4):290-295.

  3. IIlnytska O, Kaur S, Chon S, et al. Colloidal oatmeal (Avena Sativa) improves skin barrier through multi-therapy activity. J Drugs Dermatol. 2016 Jun 1;15(6):684-690. PMID: 27272074

  4. Reynertson KA, Garay M, Nebus J, et al. Anti-inflammatory activities of colloidal oatmeal (avena sativa) contribute to the effectiveness of oats in treatment of itch associated with dry, irritated skin. J Drugs Dermatol. 2015;14(1):43-48.